Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT
暂无分享,去创建一个
A. Ganser | S. Iacobelli | M. Robin | A. Nagler | J. Snowden | M. Aljurf | J. Passweg | T. D. de Witte | P. Reményi | Y. Chalandon | G. Helbig | R. Niittyvuopio | E. Olavarría | P. Browne | S. Masouridi-Levrat | P. Hayden | N. Kroeger | E. Morozova | H. Sengeloev | I. Y. Agha | H. L. Wallet | G. van Gorkom | J. Hoek | Henric-Jan Blok | G. V. van Gorkom | Gwendolyn N Y van Gorkom | Gwendolyn N. Y. van Gorkom